Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort

Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM

Thermo Fisher Scientific opens Bay Area cryo-EM Drug Discovery Center

GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care

iLoF collaborates with Bluepharma to deploy AI-powered Optomics

Akeso agrees clinical trial collaboration with INOVIO

Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation

Frontage Laboratories acquires Teddy Clinical Research Laboratory in China

Allergy Therapeutics reports positive biomarker data from PROTECT trial

HUTCHMED doses first patient in global trial of ATTC candidate HMPL-A580

Ensorcell adds new senior leadership team members

Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens

Sanaregen receives FDA clearance for retinal degeneration clinical trial

Lynk Pharmaceuticals reveals positive topline results from zemprocitinib Phase III clinical trial

ReviR Therapeutics doses first participant in First-in-Human Phase 1 clinical trial of RTX-117